AnaptysBio Shares Outstanding 2014-2021 | ANAB

AnaptysBio shares outstanding from 2014 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
AnaptysBio Annual Shares Outstanding
(Millions of Shares)
2020 27
2019 27
2018 25
2017 20
2016 3
2015 3
2014 2
2013 8
AnaptysBio Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 27
2021-03-31 27
2020-12-31 27
2020-09-30 27
2020-06-30 27
2020-03-31 27
2019-12-31 27
2019-09-30 27
2019-06-30 27
2019-03-31 27
2018-12-31 25
2018-09-30 24
2018-06-30 24
2018-03-31 24
2017-12-31 20
2017-09-30 20
2017-06-30 20
2017-03-31 15
2016-12-31 3
2016-09-30 3
2016-06-30 3
2016-03-31 3
2015-12-31
2014-12-31
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.783B $0.075B
AnaptysBio, Inc. is a biotechnology company. It involved in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology primarily in the Unites states. AnaptysBio, Inc. is based in San Diego, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $128.460B 8.55
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.211B 20.68
Biohaven Pharmaceutical Holding (BHVN) United States $8.952B 0.00
Emergent Biosolutions (EBS) United States $2.717B 6.55
Arcus Biosciences (RCUS) United States $2.502B 0.00
Myovant Sciences (MYOV) United Kingdom $1.906B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.820B 0.00
Zymeworks (ZYME) Canada $1.088B 0.00
Ambrx Biopharma (AMAM) United States $0.513B 0.00
SQZ Biotechnologies (SQZ) United States $0.343B 0.00
Enzo Biochem (ENZ) United States $0.159B 15.57